TCTR20170827002CompletedPhase 4
The effect of selenium supplementation in moderate-to-severe thyroid eye disease patients : a randomized-placebo controlled trial
The Ratchadapiseksompotch Fund, Faculty of Medicine0 sites46 target enrollmentStarted: August 27, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 46
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •1.The patients who have been categorized into moderate-to-severe thyroid eye disease group according to EUGOGO recommendation.
- •2. Age above 18 years old
- •3. The patients with normal thyroid hormone level (FT4, FT3) for at least 6 months
- •4. The patients who presented with thyroid eye symptoms of less than 18 months.
Exclusion Criteria
- •1. The patients who have history of allergic reaction to selenium
- •2. The patients who previously took or who are currently taking selenium supplement.
- •3. The patients who are pregnant or breast-feeding.
Investigators
Similar Trials
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Not yet recruiting
Phase 3
The effect of supplementation with organic selenium on sperm parameters, serum levels of androgens, sexual function, and quality of sexual life in infertile meMale infertilityIRCT20131009014957N11Tabriz University of Medical Sciences80
Completed
Phase 2
The effect of selenium on nephropathy complications of diabetic patientsnon-insulin-dependent diabetes mellitus with renal complicationsE11.2diabetic nephropathy.IRCT2015060622562N1Vice chancellor for research, Kashan University of Medical Sciences60
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Completed
Phase 2
Investigation of the effect of Selenium in beta thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20180603039959N3Ahvaz University of Medical Sciences42